hotspot -WSS

hotspot

author：entertainment 2025-09-29 21:12:42 - browse：7

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Bird flu surveillance in wastewater gets boost from consortium

WSS

Biogen joins immunology wave with $1.15 billion acquisition of HI

Adopting new red light myopia treatments may be short

Eyeing GLP

What’s missing from the debate over nursing home staff minimums

Unique patient identifier: Experts argue the benefits, pitfalls

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

focus

hotspot

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Listen: More tumult at BIO & coercive care for sickle cell patients

Virginia high school admissions case could be legal follow

Addressing health care workers' trauma can help fight burnout

Virginia high school admissions case could be legal follow

Addressing health care workers' trauma can help fight burnout

Peter Hotez and the public health issue of online harassment

Updated Covid vaccine has 54% effectiveness, new study suggests

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cano Health’s bankruptcy is a warning for Medicare Advantage

entertainment

Bird flu surveillance in wastewater gets boost from consortium

As a primary care physician, here's how I hope to partner with AI

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Fentanyl is making it harder to start addiction treatment

AI gets buy

Citing H5N1 threat, CDC urges peak flu monitoring this summer

focus

focus

hotspot

Wikipedia